The management of retinal vein occlusion: is interventional ophthalmology the way forward?
The management of retinal vein occlusion: is interventional ophthalmology the way forward?
Retinal vein occlusions (RVO) are the second commonest sight threatening vascular disorder. Despite its frequency treatments for RVO are unsatisfactory and include several that have not been tested by large, well designed, prospective, randomised controlled trials. There is also the lack of long term follow up in many of the available small uncontrolled studies, and the timings of interventions are haphazard. This review aims to evaluate the current knowledge relating to the pathogenesis, suggested treatments for the different types of RVO, and their complications. Isovolaemic haemodilution is of limited benefit and should be avoided in patients with concurrent cardiovascular, renal, or pulmonary morbidity. Evidence to date does not support any therapeutic benefit from radial optic neurotomy, optic nerve decompression, or arteriovenous crossing sheathotomy on its own. Vitrectomy combined with intravenous thrombolysis may offer promise for central RVO. Similarly, vitrectomy combined with arteriovenous sheathotomy intravenous tissue plasminogen activator may offer benefits for branch RVO. RVOs occur at significantly high frequency to allow future prospective randomised controlled studies to be conducted to evaluate the role of different therapeutic modalities singly or in combination.
retinal vein occlusion, steroids
627-639
Shahid, H.
a3a2f975-0c97-4608-ae8c-0c514514a02c
Hossain, P.
563de5fc-84ad-4539-9228-bde0237eaf51
Amoaku, W.M.
2ed85882-4d83-4223-8f26-459043a098a2
May 2006
Shahid, H.
a3a2f975-0c97-4608-ae8c-0c514514a02c
Hossain, P.
563de5fc-84ad-4539-9228-bde0237eaf51
Amoaku, W.M.
2ed85882-4d83-4223-8f26-459043a098a2
Shahid, H., Hossain, P. and Amoaku, W.M.
(2006)
The management of retinal vein occlusion: is interventional ophthalmology the way forward?
British Journal of Ophthalmology, 90 (5), .
(doi:10.1136/bjo.2005.068668).
Abstract
Retinal vein occlusions (RVO) are the second commonest sight threatening vascular disorder. Despite its frequency treatments for RVO are unsatisfactory and include several that have not been tested by large, well designed, prospective, randomised controlled trials. There is also the lack of long term follow up in many of the available small uncontrolled studies, and the timings of interventions are haphazard. This review aims to evaluate the current knowledge relating to the pathogenesis, suggested treatments for the different types of RVO, and their complications. Isovolaemic haemodilution is of limited benefit and should be avoided in patients with concurrent cardiovascular, renal, or pulmonary morbidity. Evidence to date does not support any therapeutic benefit from radial optic neurotomy, optic nerve decompression, or arteriovenous crossing sheathotomy on its own. Vitrectomy combined with intravenous thrombolysis may offer promise for central RVO. Similarly, vitrectomy combined with arteriovenous sheathotomy intravenous tissue plasminogen activator may offer benefits for branch RVO. RVOs occur at significantly high frequency to allow future prospective randomised controlled studies to be conducted to evaluate the role of different therapeutic modalities singly or in combination.
This record has no associated files available for download.
More information
Published date: May 2006
Keywords:
retinal vein occlusion, steroids
Identifiers
Local EPrints ID: 27418
URI: http://eprints.soton.ac.uk/id/eprint/27418
ISSN: 0007-1161
PURE UUID: 0f106171-24ec-4cf6-ab1b-72e5d607646e
Catalogue record
Date deposited: 25 Apr 2006
Last modified: 16 Mar 2024 03:47
Export record
Altmetrics
Contributors
Author:
H. Shahid
Author:
W.M. Amoaku
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics